ArticleArchives of dermatological research2025
Solitary and multiple xanthogranulomas in adult patients: a single-center retrospective cohort study.
Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multiple adult xanthogranulomas associated with breast cancer.JAAD case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The systemic associations of adult xanthogranulomas (XGs), the most common subtype of non-Langerhans cell histiocytosis, are poorly understood. In this retrospective cohort analysis, we studied adult patients diagnosed with XGs and investigated the clinical features and systemic associations of adult XGs. Among 138 patients (mean age 43.3 years, 51.4% female, 76.8% white), adult XGs most frequently presented on the trunk (40.6%), differing from the pediatric predilection for the head and neck. Patients presenting with multiple XGs (3.6%) were significantly more likely to have systemic malignancies (p = 0.009), particularly hematologic malignancies (p = 0.001), as well as non-malignant hematologic disorders (p = 0.027). Hyperlipidemia (37%), cardiac disease (51.4%), and endocrine disease (31.2%) were the most prevalent systemic comorbidities. In conclusion, the presentation of multiple XGs in an adult is associated with malignancy (particularly hematologic malignancies) and non-malignant hematologic disorders, suggesting a possible link with immune dysregulation. Molecular testing in one patient with multiple XGs and CMML transformed to AML revealed the same KMT2a deletion in both the XGs and the bone marrow, raising the possibility of clonal relationships in some cases.
Indexed as
Identifiers
40167771What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.